Mostafa Borahay

Has grant

Associate Professor

Johns Hopkins University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mostafa Borahay is an Associate Professor at Johns Hopkins Medicine in the United States. His research areas include women's health, nanomedicine, and economic evaluations of lifestyle interventions in prenatal care. He has contributed to various studies focused on adenomyosis treatment, gestational weight gain, and the implications of COVID-19 on menstrual health. His work aims to address disparities in gynecological health, particularly among Black women.

Recent Grants

Grant: Close

Mechanisms of actions(s) of simvastatin in uterine leiomyoma

Open Date: 2018-08-01

Close Date: 2023-07-31

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Emmanuel Drabo

Johns Hopkins University

UNITED STATES

View details

Bulent Ozpolat

Assoc. Prof.Dr.

Houston Methodist

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mostafa Borahay

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Protocol for the economic evaluation of the “Healthy for Two/Healthy for You” pragmatic lifestyle intervention in prenatal care to reduce gestational weight gain and gestational diabetes mellitus

Simvastatin-loaded liposomal nanoparticles as treatment for adenomyosis in a patient-derived xenograft mouse model: a pilot study

Addressing the crisis in women’s health research: an American Gynecological and Obstetrical Society statement

Feasibility and Perioperative Outcomes of Minimally Invasive Higher Order Myomectomy

The fibroid crisis in Black women: more work to be done!

The association of COVID-19 vaccination and menstrual health: A period-tracking app-based cohort study

Hypoxia in Uterine Fibroids: Role in Pathobiology and Therapeutic Opportunities

Common Beverage Consumption and Benign Gynecological Conditions

The Role of Nanomedicine in Benign Gynecologic Disorders

Patient Characteristics Associated With Embolization Versus Hysterectomy for Uterine Fibroids: A Systematic Review and Meta-Analysis

Obesity Contributes to Transformation of Myometrial Stem-Cell Niche to Leiomyoma via Inducing Oxidative Stress, DNA Damage, Proliferation, and Extracellular Matrix Deposition

Perioperative opioid dispensing and persistent use after benign hysterectomy: a systematic review and meta-analysis

Association of Surgical Start Time with Outcomes of Benign Hysterectomy

Cost drivers for benign hysterectomy within a health care system: Influence of patient, perioperative, and hospital factors

Uterine Transcriptome: Understanding Physiology and Disease Processes

Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications

Adipocyte coculture induces a pro-inflammatory, fibrotic, angiogenic, and proliferative microenvironment in uterine leiomyoma cells

Simvastatin-loaded liposome nanoparticles treatment for uterine leiomyoma in a patient-derived xenograft mouse model: a pilot study.

Simvastatin reduces plasma membrane caveolae and caveolin-1 in uterine leiomyomas

Predictors of new persistent opioid use after benign hysterectomy in the United States

Collaborators (2)

Emmanuel Drabo

Bulent Ozpolat

Make your next move.